Inhalers can either be short-acting or long-acting, and they are used for different reasons. Combination inhalers contain two or three different drugs, like bronchodilators or a bronchodilator and a ...

Stiolto Respimat (tiotropium bromide/olodaterol) is an inhaled medication for the treatment of chronic obstructive pulmonary disease (COPD), bronchitis, and emphysema. However, it is not indicated for ...

Stiolto Respimat (tiotropium bromide/olodaterol) is an inhaled medication for the treatment of chronic obstructive pulmonary disease (COPD), bronchitis, and emphysema. It’s not indicated as a ...

Stiolto Respimat (tiotropium bromide and olodaterol) is a prescription drug used to treat chronic obstructive pulmonary disease (COPD). Stiolto Respimat can cause side effects that range from mild to ...

Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company’s inhalers is now available. Boehringer's first-of-its-kind program automatically ...

Boehringer’s first-of-its-kind program automatically reduces the costs of its COPD and asthma inhalers at the pharmacy counter for vast majority of eligible patients Program provides predictable, ...

Breathe easier when you choose the pain-free Combivent Respimat inhaler. COMBIVENT RESPIMAT Inhalation Spray is supplied in a carton containing one COMBIVENT RESPIMAT cartridge and one COMBIVENT ...

AstraZeneca (NASDAQ:AZN) plans to cap out-of-pocket costs for its inhaler medications at $35 per month following Congressional criticism of the company's pricing of the products in the US. The cap, ...

Starting June 1, Boehringer Ingelheim plans to cap inhaler products for respiratory diseases at $35 per month for eligible patients. Boehringer Ingelheim announced plans to limit the out-of-pocket ...

WASHINGTON, D.C. -- Inhaler manufacturer Boehringer Ingelheim will cap the out-of-pocket price of its inhalers following an investigation by a Senate committee, Sen. Tammy Baldwin announced Thursday.

March 7 (Reuters) - Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German drugmaker ...

Avoid spraying COMBIVENT RESPIMAT into your eyes. COMBIVENT RESPIMAT may increase eye pressure which may cause or worsen some types of glaucoma. If you have sudden vision changes, eye pain or visual ...